Ocular Surgery News U.S. Edition Current Issue
The following articles appeared in the print edition of Ocular Surgery News U.S. Edition.
Table of Contents
- New steroid options allow surgeons to better tailor postoperative treatment
-
- AbbVie to acquire Allergan for $63 billion
- Automated OCT for after-hours care aids in patient management
- Glaukos acquires Dose Medical, moves into retinal space
- Global trachoma risk reduced by 91% since 2002, WHO says
- New treatments emerging to prevent neuromyelitis optica relapse
- RVO patients at risk for loss to follow-up after anti-VEGF treatment
- VIDEO: Genetic testing moves to front of eye
- VIDEO: Two Blind Brothers share their mission to cure inherited retinal disease
-
- Hand positioning important during cataract surgery Uday Devgan, MD
- Preferences differ for LASIK enhancement procedure Cathleen M. McCabe, MD; David A. Goldman, MD
- Woman presents with slowly progressive unilateral vision loss Andre J. Witkin, MD; Sarah E. Thornton, MD; Laurel N. Vuong, MD
- Tri-Moxi controls postop inflammation
- Patient-centered advances enhance post-cataract surgery regimens Richard L. Lindstrom, MD
- Is there still a future for postoperative topical steroid drops?
- The dry eye suggestion box Darrell E. White, MD